These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10502426)

  • 1. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening.
    Plaxe SC; Saltzstein SL
    Gynecol Oncol; 1999 Oct; 75(1):55-61. PubMed ID: 10502426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
    Smith HO; Tiffany MF; Qualls CR; Key CR
    Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
    Sherman ME; Wang SS; Carreon J; Devesa SS
    Cancer; 2005 Mar; 103(6):1258-64. PubMed ID: 15693030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases)].
    Monchy D; Lieng CR; Kruy LS; Kahler K; Eav S
    Bull Soc Pathol Exot; 2005 Sep; 98(3):183-6. PubMed ID: 16267957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe cervical glandular cell lesions with coexisting squamous cell lesions.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):218-27. PubMed ID: 15368313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-pathologic study on the early diagnosis of cervical adenocarcinoma].
    Obata N; Sasaki A; Takeuchi S; Ishiguro Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):771-6. PubMed ID: 3598272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
    Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
    Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
    BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
    Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with tumour stage at presentation in invasive cervical cancer.
    Ndlovu N; Kambarami R
    Cent Afr J Med; 2003; 49(9-10):107-11. PubMed ID: 15298465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
    Smrkolj S; Rakar S; Mozina A; Erzen M
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive carcinoma of the uterine cervix associated with pregnancy: 90 years of experience.
    Pettersson BF; Andersson S; Hellman K; Hellström AC
    Cancer; 2010 May; 116(10):2343-9. PubMed ID: 20209612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in epidemiology and clinical characteristics of cervical cancer over the past 50 years.
    Zhao EF; Bao L; Li C; Song L; Li YL
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):605-9. PubMed ID: 15958289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [No major difference between population screening for cervical carcinoma at the present screening interval of 5 years and the former interval of 3 years].
    Vinkesteijn AS; Siemens FC; Boon ME; Kuypers JC; Kok LP
    Ned Tijdschr Geneeskd; 2004 Sep; 148(36):1781-5. PubMed ID: 15495942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glandular lesions of the uterine cervix.
    Zaino RJ
    Mod Pathol; 2000 Mar; 13(3):261-74. PubMed ID: 10757337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.